c-Met inhibitor
Showing 26 - 50 of >10,000
Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)
Not yet recruiting
- Metastatic Colorectal Cancer
- (no location specified)
Oct 31, 2023
Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)
Active, not recruiting
- Refractory Soft Tissue Sarcomas
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022
Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)
Active, not recruiting
- Advanced Hepatocellular Carcinoma With c-MET Dysregulation
-
Nanjing, Jiangsu, China
- +7 more
Jan 12, 2023
Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- +2 more
- (no location specified)
Jul 21, 2023
Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced Colon Cancer
- Serplulimab
- +3 more
- (no location specified)
Feb 16, 2023
NSCLC Trial in Worldwide (INC280, Gefitinib)
Completed
- Non-small Cell Lung Cancer
-
Woolloongabba, Queensland, Australia
- +30 more
Mar 12, 2021
NSCLC Trial in Guangzhou (PLB1001)
Completed
- Non-Small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Nov 20, 2019
Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)
Not yet recruiting
- Metastatic Breast Cancer
- Breast Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 16, 2022
Posterior Brain Fossa Tumors in Children Trial in Bron (11C-MET PET/MRI)
Completed
- Posterior Brain Fossa Tumors in Children
- 11C-MET PET/MRI
-
Bron, FranceHospices Civils de Lyon - Groupement Hospitalier Est - Hôpital F
Nov 29, 2021
Healthy Adults Trial in Dallas (Treatment A, Treatment B)
Not yet recruiting
- Healthy Adults
- Treatment A
- Treatment B
-
Dallas, TexasLabcorp Clinical Research Unit Inc
May 11, 2023
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)
Completed
- Sarcoma
- +2 more
- Pazopanib
- ARQ 197
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021
c-MET Expression and EGFR Gene Mutation Correlation With
Completed
- Non-small Cell Lung Cancer Metastatic
- Non-small Cell Lung Cancer Recurrent
-
Hwasun, Korea, Republic ofChonnam National University Hwasun Hospital
Aug 1, 2021
Metastatic Pancreatic Cancer Trial in Houston (MRTX849)
Not yet recruiting
- Metastatic Pancreatic Cancer
-
Houston, TexasM D Anderson Cancer Center
Nov 22, 2022
Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- Click Digital Therapeutic
-
New York, New YorkClick Therapeutics
Aug 15, 2023
Teenagers and Non-histaminergic Angioedema With Normal C1
Not yet recruiting
- Hereditary Angioedema (HAE)
- Angioedema
- No Intervention
- (no location specified)
Jan 5, 2023
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,
Active, not recruiting
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +9 more
- BTK inhibitor PCI-32765
- +5 more
-
Columbus, OhioOhio State University Medical Center
Jun 27, 2022